Medical and surgical care of patients with mesothelioma and their relatives carrying germline BAP1 mutations
The most common malignancies that develop in carriers of BAP1 germline mutations include
diffuse malignant mesothelioma, uveal and cutaneous melanoma, renal cell carcinoma, and …
diffuse malignant mesothelioma, uveal and cutaneous melanoma, renal cell carcinoma, and …
Osteopontin as a link between inflammation and cancer: the thorax in the spotlight
AS Lamort, I Giopanou, I Psallidas, GT Stathopoulos - Cells, 2019 - mdpi.com
The glycoprotein osteopontin (OPN) possesses multiple functions in health and disease. To
this end, osteopontin has beneficial roles in wound healing, bone homeostasis, and …
this end, osteopontin has beneficial roles in wound healing, bone homeostasis, and …
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
A Scherpereel, I Opitz, T Berghmans… - European respiratory …, 2020 - Eur Respiratory Soc
The European Respiratory Society (ERS)/European Society of Thoracic Surgeons
(ESTS)/European Association for Cardio-Thoracic Surgery (EACTS)/European Society for …
(ESTS)/European Association for Cardio-Thoracic Surgery (EACTS)/European Society for …
Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma
A Scherpereel, P Astoul, P Baas… - European …, 2010 - Eur Respiratory Soc
Malignant pleural mesothelioma (MPM) is a rare tumour but with increasing incidence and a
poor prognosis. In 2008, the European Respiratory Society/European Society of Thoracic …
poor prognosis. In 2008, the European Respiratory Society/European Society of Thoracic …
Malignant pleural effusion: from bench to bedside
Malignant pleural effusion (MPE) is a common but serious condition that is related with poor
quality of life, morbidity and mortality. Its incidence and associated healthcare costs are …
quality of life, morbidity and mortality. Its incidence and associated healthcare costs are …
Malignant mesothelioma
BWS Robinson, AW Musk, RA Lake - The Lancet, 2005 - thelancet.com
Malignant mesothelioma is an aggressive, treatment-resistant tumour, which is increasing in
frequency throughout the world. Although the main risk factor is asbestos exposure, a virus …
frequency throughout the world. Although the main risk factor is asbestos exposure, a virus …
Malignant mesothelioma: facts, myths, and hypotheses
M Carbone, BH Ly, RF Dodson… - Journal of cellular …, 2012 - Wiley Online Library
Malignant mesothelioma (MM) is a neoplasm arising from mesothelial cells lining the
pleural, peritoneal, and pericardial cavities. Over 20 million people in the US are at risk of …
pleural, peritoneal, and pericardial cavities. Over 20 million people in the US are at risk of …
The significance of SPP1 in lung cancers and its impact as a marker for protumor tumor-associated macrophages
E Matsubara, H Yano, C Pan, Y Komohara, Y Fujiwara… - Cancers, 2023 - mdpi.com
Simple Summary Macrophages that infiltrate the cancer microenvironment are referred to as
tumor-associated macrophages (TAMs). Phosphoprotein 1 (SPP1), also known as …
tumor-associated macrophages (TAMs). Phosphoprotein 1 (SPP1), also known as …
Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma
LM Krug, HI Pass, VW Rusch, HL Kindler… - Journal of Clinical …, 2009 - ascopubs.org
Purpose Neoadjuvant pemetrexed plus cisplatin was administered, followed by extrapleural
pneumonectomy (EPP) and hemithoracic radiation (RT), to assess the feasibility and efficacy …
pneumonectomy (EPP) and hemithoracic radiation (RT), to assess the feasibility and efficacy …
[HTML][HTML] Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma
HI Pass, SM Levin, MR Harbut… - … England Journal of …, 2012 - Mass Medical Soc
Background New biomarkers are needed to detect pleural mesothelioma at an earlier stage
and to individualize treatment strategies. We investigated whether fibulin-3 in plasma and …
and to individualize treatment strategies. We investigated whether fibulin-3 in plasma and …